Anti-VLA-4 monoclonal antibody HP1/2
Latest Information Update: 07 Mar 2007
At a glance
- Originator Biogen
- Class Anti-inflammatories; Monoclonal antibodies
- Mechanism of Action Integrin alpha4beta1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 10 Aug 2000 No-Development-Reported for Inflammation in USA (Unknown route)